)
Edge28 Nov 2025
Keeping the Streak Alive: The Story of Duolingo
How Duolingo made language learning addictive, scaled to millions of users, and built a powerful subscription business around everyday practice.
Teva Pharmaceutical Industries (TEVA) investor relations material
Teva Pharmaceutical Industries Citi Annual Global Healthcare Conference 2025 summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Citi Annual Global Healthcare Conference 2025 summary4 Dec, 2025
Strategic transformation and growth journey
Pivot to Growth strategy shifted focus from generics to biopharma, with significant progress in business structure and financials over three years.
Innovative products like AUSTEDO, UZEDY, and AJOVY are driving growth, with AUSTEDO expected to surpass $3 billion in peak sales.
Pipeline transformation accelerated, with multiple late-stage assets including olanzapine, DARI, and duvakitug advancing toward launch.
Global generics business stabilized and returned to growth, contributing to overall value creation.
Effective capital allocation and cost-saving programs are supporting EBITDA and EPS growth.
Financial outlook and margin expansion
Despite losing over $1 billion in Revlimid sales in 2026, EBITDA is expected to grow through high-margin innovative launches and $500 million in cost savings by end of 2026.
Gross margin projected to rise from 48% in early 2023 to 54% by year-end, with further increases to 57–58% by 2027 and continued growth through 2032.
Innovative portfolio growth, including new launches each year, is the main driver of margin expansion and financial performance.
Product portfolio and market dynamics
AUSTEDO's IRA-negotiated price reduction provides certainty for $2.5 billion in 2027 sales and over $3 billion peak, with continued focus on patient access and adherence.
UZEDY and upcoming olanzapine launch are expected to significantly expand the schizophrenia franchise to $1.5–2 billion.
Duvakitug (TL1A) in partnership with Sanofi targets $3–5 billion in UC and CD, with additional indications planned.
Commercial execution emphasizes value over access, maintaining price discipline even in competitive markets.
How will Teva sustain gross margin growth through 2032?
How will pipeline launches impact future EBITDA?
How will PBMs impact biosimilar growth in the US?
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Next Teva Pharmaceutical Industries earnings date
Q4 202528 Jan, 2026
Next Teva Pharmaceutical Industries earnings date
Q4 202528 Jan, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets and distributes generic medicines and a portfolio of specialty medicines worldwide. It operates in two segments, Generic Medicines and Specialty Medicines. The company offers various APIs and molecules for the treatment of various disorders in a range of therapeutic areas, including CNS, oncology, respiratory, cardiology and other specialty areas. The company was founded in 1901 and is headquartered in Tel Aviv-Yafo, Israel.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage